Prescription drug · ANDA
Doxazosin (Doxazosin mesylate) NDC 50090-6298
Doxazosin mesylate 4 mg/1 · Tablet · Oral · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-6298-0 | 5009062980050090629800 | 30 TABLET in 1 BOTTLE (50090-6298-0)Marketed from Dec 29, 2022 | |
| 50090-6298-1 | 5009062980150090629801 | 100 TABLET in 1 BOTTLE (50090-6298-1)Marketed from Dec 29, 2022 | |
| 50090-6298-2 | 5009062980250090629802 | 90 TABLET in 1 BOTTLE (50090-6298-2)Marketed from Dec 29, 2022 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Doxazosin
- Generic name (nonproprietary)
- doxazosin mesylate
- Active ingredients
- Doxazosin mesylate — 4 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- A-S Medication SolutionsNDC labeler code 50090
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 209013
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Antagonists (Mechanism)
- Identifiers
- Product ID 50090-6298_5610e0a8-46eb-4037-88e9-23e46b92b0fcSPL ID 5610e0a8-46eb-4037-88e9-23e46b92b0fcSPL set ID b4c974ad-cbd6-4811-ab48-461e7ffa99f7RxCUI 197627UNII 86P6PQK0MU
- Pharmacologic class
- alpha-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450090629800followed by a unit qualifier and the quantityPackage 50090-6298-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Doxazosin tablets are an alpha 1 adrenergic antagonist indicated for: ( 1 ) Signs and symptoms of Benign Prostatic Hyperplasia (BPH) Treatment of Hypertension 1.1 Benign Prostatic Hyperplasia (BPH) Doxazosin tablets are indicated for the treatment of the signs and symptoms of BPH. 1.2 Hypertension Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. Control of high blood pressure sh…
Excerpt only. Read the full label for complete information.
About NDC 50090-6298
- What is NDC 50090-6298?
- 50090-6298 is the product NDC for Doxazosin (doxazosin mesylate), Doxazosin mesylate 4 mg/1 tablet, listed with the FDA by A-S Medication Solutions. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Doxazosin (Doxazosin Mesylate).
- What is the active ingredient?
- Doxazosin mesylate.
- Who is the labeler?
- A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Doxazosin?
- 106 other product NDCs are listed under this name. See all Doxazosin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Doxazosin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-166 | 16571-0166-01 |
| Doxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-165 | 16571-0165-01 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-167 | 16571-0167-01 |
| Doxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-168 | 16571-0168-01 |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 1 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-892 | 59651-0892-0159651-0892-99 |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 2 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-893 | 59651-0893-0159651-0893-99 |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 4 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-894 | 59651-0894-0159651-0894-99 |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 8 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-895 | 59651-0895-0159651-0895-99 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4031 | 70518-4031-00 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-3965 | 70518-3965-0070518-3965-01 |
Other NDCs under ANDA 209013
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Doxazosindoxazosin mesylate | Doxazosin mesylate 1 mg/1 | TabletOral | Upsher-Smith laboratories, LLC | 0832-0356 |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 2 mg/1 | TabletOral | Upsher-Smith laboratories, LLC | 0832-0357 |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 4 mg/1 | TabletOral | Upsher-Smith laboratories, LLC | 0832-1358 |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 8 mg/1 | TabletOral | Upsher-Smith laboratories, LLC | 0832-1359 |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 4 mg/1 | TabletOral | Northwind Health Company, LLC | 51655-130 |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 4 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-9672 |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 2 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-482 |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 4 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-789 |